Testing a new treatment for discoid lupus erythematosus
Treatments studied
Part of Skin clinical trials.
This study tests a new drug called dihydroartemisinin, which comes from a traditional Chinese medicine, to see if it is safe and effective for treating discoid lupus erythematosus (a type of lupus that causes skin rashes and scars). The drug is given as a tablet and is compared to an existing treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You need a confirmed diagnosis of discoid lupus erythematosus (a type of lupus that mainly affects the skin).
- Your skin symptoms must be active enough to meet a certain severity score.
- You must not have systemic lupus erythematosus (lupus affecting internal organs) or be at high risk for it.
- You cannot have used certain treatments (like hydroxychloroquine) recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream (ruxolitinib) on discoid lupus skin lesions. It aims to see if the cream can reduce DLE symptoms in adults.
This trial tests an experimental drug called ICP-488 for people with active cutaneous lupus erythematosus (CLE), a type of lupus that affects the skin. It aims to see if the drug can reduce skin inflammation and improve symptoms.
This trial tests two new drugs, BCD-256-1 and divozilimab, for people with systemic lupus erythematosus (SLE) who have active skin symptoms not controlled by current treatments. The goal is to see if they are safe and how the body processes them.
This study tests a new investigational drug called SCTB35 for people with active systemic lupus erythematosus (SLE or lupus). It aims to see if the drug is safe and effective in controlling lupus activity when added to your current stable lupus medications.
This trial tests an investigational drug called AZD0120 in adults with lupus that hasn't improved with standard treatments. The goal is to see if it's safe and works well for people with lupus-related organ problems.
This trial tests a new treatment for people with active lupus who haven't responded well to steroids and at least two other immune-suppressing drugs, including a biologic. It aims to find a better option for controlling lupus symptoms.
Hear when a new Discoid Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.